Page, Raymond L.
Current skeletal muscle cell therapy systems have limited effectiveness due to poor proliferative capability. The cells are not functional enough to be implanted into a critical size muscle defect as a therapy for volumetric muscle loss. Altering in vitro factors, such as mitogens and oxygen tension, can have a favorable effect on the cells ability to retain myogenic potential. Individual system parameters were characterized through experimental testing of culture conditions, media composition, and cell kinetics. Our team designed, engineered, and validated a final scalable cell expansion system for proliferating myogenic cells in vitro.
Worcester Polytechnic Institute
Major Qualifying Project
All authors have granted to WPI a nonexclusive royalty-free license to distribute copies of the work, subject to other agreements. Copyright is held by the author or authors, with all rights reserved, unless otherwise noted.